Rare diseases
Investigational molecules
Locations
BMS-986525 Alone and with Nivolumab in Patients with Relapsed or Refractory Small Cell Lung Cancer
RomaniaNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
RomaniaLong-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
RomaniaPumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%
RomaniaQTX-2101 and Arsenic Trioxide in Adult Patients With Acute Promyelocytic Leukemia
RomaniaRO7795068 for Weight Loss in Adults With Obesity or Overweight and Type 2 Diabetes
RomaniaGB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
RomaniaA Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer
RomaniaPhase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients
RomaniaBMN 333 Versus Vosoritide in Children With Achondroplasia
RomaniaFWY003 in Geographic Atrophy Secondary to Age-Related Macular Degeneration in Patients
RomaniaA Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes
RomaniaTell us about your condition – we search every trial in Europe and connect you with the right site.
